Join to View Full Profile
1201 NW 16th StD1010Miami, FL 33125
Phone+1 305-575-3143
Fax+1 305-575-3375
Dr. Byrnes is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John Byrnes is an oncologist in Miami, FL and is affiliated with multiple hospitals in the area, including University of Miami Hospital and University of Miami Hospital and Clinics. He received his medical degree from Tufts University School of Medicine and has been in practice 49 years. He is experienced in amyloidosis, hematologic oncology, thrombotic microangiopathy, myelodysplasia, and myelofibrosis. He has more than 40 publications and over 500 citings.
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 1970 - 1973
University at BuffaloResidency, Internal Medicine, 1969 - 1970- University at Buffalo School of MedicineInternship, Transitional Year, 1968 - 1969
Tufts University School of MedicineClass of 1968
Certifications & Licensure
FL State Medical License 1973 - 2026
MD State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Diagnostic Laboratory Immunology
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Elected Member The American Society for Clinical Investigation, 1983
Publications & Presentations
PubMed
- 4 citationsThe Diagnosis Is in the Smear: A Case and Review of Spur Cell Anemia in Cirrhosis.Gabriella A. Raffa, Diana M. Byrnes, John J. Byrnes
Case Reports in Hematology. 2021-03-26 - 48 citationsImpact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients.Jose F. Camargo, Erik Kimble, Rossana Rosa, Luis Shimose, Maria X. Bueno
Biology of Blood and Marrow Transplantation. 2017-12-01 - 130 citationsDose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)Victoria Florea, Angela C. Rieger, Darcy L. DiFede, Jill El-Khorazaty, Makoto Natsumeda
Circulation Research. 2017-11-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
